Comparing Cardinal Health and Lifevantage: A Stock Analysis

Investors are weighing their options between two prominent medical companies, **Cardinal Health** (NYSE:CAH) and **Lifevantage** (NASDAQ:LFVN), as analysts provide insights into their financial health and future potential. This analysis will explore various factors including risk, dividends, earnings, profitability, analyst recommendations, and institutional ownership to determine which stock may be more favorable for investment.

Analyst Recommendations

Current ratings indicate a significant disparity in potential upside between the two companies. According to MarketBeat.com, **Cardinal Health** has a consensus target price of **$212.60**, suggesting a potential upside of **5.74%**. In contrast, **Lifevantage** boasts a much higher consensus target price of **$23.50**, reflecting a remarkable potential upside of **262.10%**. Analysts appear to favor Lifevantage for its higher upside potential, indicating a more optimistic outlook.

Valuation and Earnings

Examining revenue and earnings reveals that **Cardinal Health** outperforms **Lifevantage** in both categories. The larger company’s established market presence allows it to generate higher earnings. On the other hand, Lifevantage is trading at a lower price-to-earnings ratio, which suggests that it might be a more affordable investment option at this time.

Profitability metrics further illustrate the differences between the two companies. Cardinal Health maintains stronger net margins and return on equity compared to Lifevantage, underscoring its more robust financial performance.

Risk and volatility are critical considerations for investors. **Cardinal Health** has a beta of **0.65**, indicating that its share price is approximately **35%** less volatile than the S&P 500. Conversely, Lifevantage has a beta of **0.34**, suggesting its share price is **66%** less volatile than the broader market. Both companies demonstrate lower volatility compared to many stocks, presenting a potentially safer investment avenue.

Insider and Institutional Ownership

Examining ownership structures reveals notable differences in institutional and insider holdings. Approximately **87.2%** of Cardinal Health shares are held by institutional investors, signaling strong confidence from large money managers and hedge funds in its long-term growth prospects. In contrast, **35.3%** of Lifevantage shares are held by institutional investors, indicating a lesser degree of institutional backing. Additionally, only **0.1%** of Cardinal Health shares are owned by company insiders compared to **22.0%** for Lifevantage, suggesting a greater personal investment from Lifevantage’s management.

Dividends

Dividends play a significant role in attracting investors. **Cardinal Health** offers an annual dividend of **$2.04** per share, resulting in a **1.0%** yield, while **Lifevantage** pays an annual dividend of **$0.18** per share, yielding **2.8%**. Cardinal Health distributes approximately **30.8%** of its earnings as dividends, while Lifevantage has a lower payout ratio of **23.4%**. This indicates that both companies have healthy payout ratios and should continue to cover their dividends with earnings in the coming years. Notably, Cardinal Health has increased its dividend for **29 consecutive years**, while Lifevantage has done so for **3 consecutive years**, marking a significant achievement for both firms.

Company Overview

**Cardinal Health, Inc.** is a leading healthcare services and products company with a global footprint, operating in the United States, Canada, Europe, and Asia. Founded in **1979** and headquartered in **Dublin, Ohio**, it specializes in providing customized solutions for hospitals, pharmacies, and healthcare systems. The company has two main segments: Pharmaceutical and Medical, which encompass a range of services from drug distribution to medical product manufacturing.

On the other hand, **LifeVantage Corporation**, founded in **2003** and based in **Lehi, Utah**, focuses on nutrigenomic activators and dietary supplements. Its product portfolio includes a variety of health-focused supplements and skincare products, which are marketed through a network of independent distributors in multiple countries.

In summary, when comparing **Cardinal Health** and **Lifevantage**, Cardinal Health excels in revenue and profitability metrics, while Lifevantage offers greater potential upside and a higher dividend yield. Investors must weigh these factors according to their individual investment strategies and risk tolerance levels.